Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Genes|October 23, 2021
Immune Profiling of Medullary Thyroid Cancer-An Opportunity for ImmunotherapyKinga Hińcza-Nowak, Artur Kowalik, Agnieszka Walczyk, et al.
International Journal of Molecular Sciences|June 28, 2023
CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid CancerKinga Hińcza-Nowak, Artur Kowalik, Agnieszka Walczyk, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 19, 2025
A Novel Classification Proposal for Iatrogenic Arteriovenous Fistulas and Pseudoaneurysms After Transfemoral Cardiovascular Interventions-An Analysis of a Single-Center Database of 5941 PuncturesJacek Kurzawski, Łukasz Zandecki, Marianna Janion, et al.
Endocrinology|July 16, 2019
Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid CancerTomasz Trybek, Agnieszka Walczyk, Danuta Gąsior-Perczak, et al.
Clinical and Experimental Medicine|May 12, 2025
Risk characteristics of papillary thyroid cancer > 1-4 cm is associated with increased tumour sizeAgnieszka Walczyk, Danuta Gąsior-Perczak, Iwona Pałyga, et al.
Oncotarget|September 24, 2017
The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish populationArtur Kowalik, Danuta Gąsior-Perczak, Martyna Gromek, et al.
Endocrine Pathology|April 3, 2020
Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?Janusz Kopczyński, Agnieszka Suligowska, Kornelia Niemyska, et al.
Thyroid : Official Journal of the American Thyroid Association|February 19, 2016
Increase in Papillary Thyroid Cancer Incidence Is Accompanied by Changes in the Frequency of the BRAF V600E Mutation: A Single-Institution StudyAldona Kowalska, Agnieszka Walczyk, Artur Kowalik, et al.
Cancers|November 10, 2019
Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease CourseDanuta Gąsior-Perczak, Artur Kowalik, Agnieszka Walczyk, et al.
Oncotarget|November 2, 2017
Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinomaMonika Szymonek, Artur Kowalik, Janusz Kopczyński, et al.
Pageof 4